Phil Gold | Academic Influence

Phil Gold's AcademicInfluence.com Rankings

Phil Gold

Biology

#2411

World Rank

#3829

Historical Rank

Biochemistry

#501

World Rank

#587

Historical Rank

biology Degrees

Phil Gold

Philosophy

#6037

World Rank

#8999

Historical Rank

Logic

#3336

World Rank

#4477

Historical Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Phil Gold's Degrees

Doctorate Medicine McGill University
PhD Biochemistry McGill University

Why Is Phil Gold Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Phil Gold is a Canadian physician, scientist, professor and author. Born in Montreal, Quebec, he received a BSc degree in 1957, a MSc degree in 1961, a MD degree in 1961, and a PhD in 1965 from McGill University. He obtained his Royal College of Physicians and Surgeons of Canada fellowship certification in Internal Medicine in November 1966.

(See a Problem?)

Phil Gold's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES (1965) (2299)
SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM (1965) (1849)
The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. (1969) (693)
Redefined nomenclature for members of the carcinoembryonic antigen family. (1999) (397)
PHYSICOCHEMICAL STUDIES OF THE CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM (1968) (259)
Circulating antibodies against carcinoembryonic antigens of the human digestive system (1967) (194)
Cellular location of carcinoembryonic antigens of the human digestive system. (1968) (183)
beta 2-microglogulin levels in cancerous and other disease states. (1976) (169)
The preparation of purified carcinoembryonic antigen of the human digestive system from large quantities of tumor tissue. (1972) (150)
Absence of carcinoembryonic antigen‐like material in mesothelioma An immunohistochemical differentiation from other lung cancers (1979) (145)
Position of the carcinoembryonic antigen of the human digestive system in ultrastructure of tumor cell surface. (1970) (132)
Purification and Characterization of Carcino-embryonic Antigens of the Human Digestive System (1967) (103)
Carcinoembryonic antigen (CEA): molecular biology and clinical significance. (1975) (100)
Clinical applications of carcinoembryonic antigen. (1988) (100)
Metabolism of human carcinoembryonic antigen in xenogeneic animals. (1973) (97)
Carcinoembryonic antigen (CEA) in clinical medicine. Historical perspectives, pitfalls and projections (1978) (92)
Separation of Skin Reactive Intestinal Cancer Antigen from the Carcinoembryonic Antigen of Gold (1972) (85)
Human anti-CEA antibodies detected by radioimmunoelectrophoresis. (1972) (80)
Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens. (1970) (79)
Immunology and immunotherapy of colorectal cancer. (1978) (74)
Whey proteins as a food supplement in HIV-seropositive individuals. (1993) (71)
Response of lymphocytes from patients with gastrointestinal cancer to the carcinoembryonic antigen of the human digestive system (1971) (66)
Zinc as a cofactor in human immunodeficiency virus-induced immunosuppression. (1988) (66)
The detection of alpha 1-fetoprotein in patients with viral hepatitis. (1974) (64)
Antigenic reversion in human cancer. (1971) (61)
Carcinoembryonic antigen in the diagnosis and management of colorectal carcinoma. Current status. (1974) (61)
Proceedings: Intermolecular heterogeneity of the carcinoembryonic antigen. (1974) (56)
Immunologically active heterosaccharides of carcinoembryonic antigen of human digestive system. (1972) (56)
The blood group A-like site on the carcinoembryonic antigen. (1973) (55)
The isolation and characterization of tumor-specific antigens of rodent and human tumors. (1976) (55)
Alpha1-Fetoprotein in Chronic Liver Disease (1974) (50)
Preparation and isolation of immunologically active glycopeptides from carcinoembryonic antigen (CEA) (1974) (48)
Immunologic approaches to diagnosis of malignancy. (1980) (48)
Radioimmunoassay for human alpha 1 -fetoprotein. (1973) (45)
Embryonic Origin of Human Tumor-Specific Antigens (1971) (43)
Cyclooxygenase-2 expression in uveal melanoma: novel classification of mixed-cell-type tumours. (2003) (40)
Vascular involvement in relapsing polychondritis. (1977) (39)
Immunochemical studies of the intramolecular heterogeneity of the carcinoembryonic antigen (CEA) of the human digestive system. (1973) (39)
Isolation of human tumour-specific antigens associated with beta2 microglobulin. (1978) (39)
Association of HTLV-III antibodies and cellular immune status of hemophiliacs. (1984) (37)
Augmentation of Proliferation of Human Mixed Lymphocyte Culture by Human α-Fetoprotein (1977) (37)
Immunology and colonic cancer: Further evaluation of the radioimmunoassay for carcinoembryonic antigen of the human digestive system as an adjunct in cancer diagnosis (1973) (36)
Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9. (2013) (33)
Lithium-induced thyrotoxicosis. (1979) (32)
Immunohistopathologic study on carcinoembryonic antigen (CEA)‐like material and immunoglobulin a in gastric malignancies (1979) (30)
Evidence for the expression of human tumor-specific antigens associated with beta2-microglobulin in human cancer and in some colon adenomas and benign breast lesions. (1979) (27)
Opposite functions for two classes of genes of the human carcinoembryonic antigen family. (1995) (27)
Tests for carcinoembryonic antigen. Role in diagnosis and management of cancer. (1975) (26)
beta 2-Microglobulin: methods and clinical applications. (1979) (23)
Selective celecoxib-associated anaphylactoid reaction. (2003) (21)
The Carcinoembryonic Antigen (CEA): Past, Present, and Future (2020) (21)
Historical development and potential uses of tumor antigens as markers of human cancer growth. (1980) (21)
Studies of the linkage relationship of beta‐2‐microglobulin in man‐mouse somatic cell hybrids (1975) (20)
Physicochemical approach to the purification of human alpha1-fetoprotein from the ascites fluid of a hepatoma-bearing patient. (1978) (19)
Effect of splenectomy on slowing human immunodeficiency virus disease progression. (1998) (19)
Theoretical and Practical Considerations of the Utility of the Radioimmunoassay for Carcinoembryonic Antigen (CEA) In Clinical Medicine (1980) (18)
Heterogeneity of the protein moiety of carcinoembryonic antigens. (1976) (18)
Ability of anti-brain heteroantisera to distinguish thymus-derived lymphocytes in various species. (1974) (17)
Alpha(1)-fetoprotein in chronic liver disease. (1974) (17)
Immunologic diagnosis of human cancers. (1974) (17)
The role of immunology in human cancer research. (1970) (15)
Endocrinopathy and IgA deficiency. (1973) (13)
Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate. (1983) (12)
Use of a novel agarose gel-digesting enzyme for easy and rapid purification of PCR-amplified DNA for sequencing. (1992) (12)
Radioimmunoassay for 1 -fetoprotein in the serum of rats. (1972) (12)
Metabolism of Rat α1-Fetoprotein (1974) (10)
Preparation and characterization of new anti-PSMA monoclonal antibodies with potential clinical use. (2007) (10)
Cholesterol and Coronary Heart Disease: The Great Debate (1992) (10)
Leukopenia, leukoagglutinins, and low IgM in a family with severe febrile illnesses. (1973) (10)
The effect of the sequence of erythrocyte sensitization on the bis-diazotized benzidine hemagglutination reaction. (1966) (10)
Isolation of HLA and tumor antigens by means of affinity chromatography employing anti‐β2,‐microglobulin (β2m) antiserum (1978) (9)
Human tumour antigens. (1969) (8)
Interactions between sphered human red cells in tube flow: technique for measuring the strength of antigen--antibody bonds. (1982) (8)
A human colon tumour antigen associated with beta 2-microglobulin and isolated from solid tumour, serum and urine, is unrelated to carcinoembryonic antigen. (1980) (8)
Tumor-Specific Antigen in GI Cancer (1972) (8)
PHYSICAL CHEMISTRY AND IMMUNOCHEMISTRY OF CEA: ROLE OF THE PROTEIN PORTION OF THE MOLECULE IN DETERMINING TUMOR ANTIGENICITY * (1975) (7)
Oncofetal antigens. Increasing the specificity of the CEA radioimmunoassay. (1977) (7)
Augmentation of proliferation of human mixed lymphocyte culture by human alpha-fetoprotein. (1977) (6)
Carcinoembryonic antigen and alpha 1-fetoprotein in ulcerative colitis and regional enteritis. (1974) (6)
Immunological dysfunction and persistent lymphadenopathy in patients with classic hemophilia. (2009) (6)
Carcinoembryonic antigen - immunochemistry, physical chemistry and clinical implications (1974) (5)
Platyspondyly, polyarticular osteoarthritis, and absent beta-2-globulin in two brothers. (1970) (5)
CHROMOSOMAL ASSIGNMENT OF THE HL‐A COMMON ANTIGENIC DETERMINANTS IN MAN‐MOUSE SOMATIC CELL HYBRIDS * (1976) (4)
Place for an antioxidant therapy in human immunodeficiency virus (HIV) infection (1994) (4)
Alternative Medicine or Magical Healing (1998) (3)
Disseminated coccidioidomycosis: clinical, immunologic and therapeutic aspects. (1978) (3)
STUDIES ON NEPHROTOXIC ANTIBODY IN ANTILYMPHOCYTE GLOBULIN (1972) (3)
Evans' syndrome with splenic periarterial fibrosis but no serologic evidence of systemic lupus erythematosus. (1981) (2)
Hydronephrosis; a case report and a review of thirty-one cases. (1948) (2)
The isolation of the γ subunit of fetal hemoglobin (HbF) and its use in a radioimmunoassay for HbF (1980) (2)
Hepatitis B antigen, alpha-fetoglobulins and primary hepatocellular carcinoma in Ethiopia. (1976) (2)
Carcinoembryonic Antigen and Its Utility in the Diagnosis of Colonic Adenocarcinoma (1986) (2)
Solitary pulmonary granuloma with marked enhancement on dynamic CT scanning. (1988) (2)
alpha-Fetoprotein and cystic fibrosis. (1982) (2)
The Isolation and Characterizationof Tumor-specific Antigensof Rodent and HumanTumors' (1976) (2)
The isolation of the gamma subunit of fetal hemoglocin (HbF) and its use in a radioimmunoassay for HbF. (1980) (1)
Alpha1-fetorprotein concentrations in maternal serum during normal pregnancy. (1977) (1)
An unusual case of an acute hemolytic transfusion reaction caused by an autoanti-I (2011) (1)
Maternal plasma HbF levels in pregnancy. (1983) (1)
Mania leading to self-induced subcutaneous emphysema. (1983) (1)
The study of human immunoglobulins in hybrid cells: tentative assignment of the genes responsible for human heavy chain immunoglobulin production to chromosome 2. (1976) (1)
Immunologically active glycopeptides derived from CEA. (1973) (1)
RADIOIMMUNOASSAY FOR $alpha$$sub 1$-FETOPROTEIN IN THE SERUM OF RATS. (1972) (1)
Five year 1982 1987 prospective clinical and immune evaluation of hemophiliacs before and after exposure to hiv (1987) (1)
Improvement of host resistance of animal by concentrated whey protein (1989) (0)
Protein concentrate undenatured whey. (1989) (0)
Current concepts in clinical immunology--asthma therapy, immune complex disorders and antireceptor antibodies. (1980) (0)
The Detection of a rFetoprotein in Patients with Viral Hepatitis1 (1974) (0)
Metabolism of Rat arFetoprotein1 (2006) (0)
Valleproteinpraeparat, process for their preparation and use thereof (1989) (0)
Valleproteinpraeparat, method of preparation and use thereof (1990) (0)
Anti-cancer therapeutic compositions which contain whey protein concentrate (1993) (0)
Undenatured protein concentrate from whey. (1989) (0)
[Immunologic diagnosis of malignant neoplasms. II]. (1980) (0)
[beta 2 microglobulin as marker for isolating human tumoral antigens]. (1977) (0)
Isolation of HLA and tumor antigens by means of affinity chromatography employing anti-beta2-microglobulin (beta2m) antiserum. (1978) (0)
Composition de protéines de petit lait, procédé de production et application de la composition de protéines de petit-lait (1989) (0)
The Carcinoembryonic Antigen (CEA): Past, Present, and Future [MJM 1997 3: 46-66] (2020) (0)
Biologically active Molkeproteinzusammenzetzung, methods of making and using this composition. (1989) (0)
The cloud of cancer with the ever increasing silver lining (1984) (0)
Subject Index Vol. 16, 1976 (1976) (0)
The study of human immunoglobulins in hybrid cell: tentative assignment of the genes responsible for human heavy chain immunoglobulin production to chromosome 2. (1976) (0)
Whey protein composition, its production and application of whey protein composition (1989) (0)
Diagnostic et traitement du cancer de la prostate (2004) (0)
Epitope for the diagnosis and treatment of prostate cancer (2004) (0)
Lactalbumin as nutritional supplements (1989) (0)
Immunology as it relates to reproductive biology: foreword. (1977) (0)
Zinc in Human Immunodeficiency Virus Infection-Reply (1988) (0)
Risk of transmission of HTLV III/LAV from human bites [abstract] (1986) (0)
Nephritis (?) in a 2 month old infant with congenital syphilis. (1947) (0)
Reflection on the Discovery of Carcinoembryonic Antigen , Prostate-Specific Antigen , and Cancer Antigens CA 125 and CA 19-9 Moderator : (2012) (0)
The use of an undenatured whey protein concentrate from milk and dietary supplement comprising such a concentrate (1989) (0)
Immunology and colonic cancer (1973) (0)
[Immunologic diagnosis of malignant neoplasms. I]. (1980) (0)
Valleproteinpraeparat, processes for their preparation and use (1990) (0)
Metabolism of rat alpha1-fetoprotein. (1974) (0)
Historical Development and Potential Uses of Tumor Antigens as Markers of Human Cancer Growth1 (2006) (0)
Lactalbumin as food supplement (1989) (0)

This paper list is powered by the following services:

Other Resources About Phil Gold

en.wikipedia.org

What Schools Are Affiliated With Phil Gold?

Phil Gold is affiliated with the following schools:

McGill University